In Response to: "Comparing Addition of Radiotherapy in EGFR- and ALK-Positive NSCLC With Brain Metastases: Are We Evaluating the Optimal Endpoint?"
2022
https://researcherprofiles.org/profile/259899783
35074229
Journal Issue
Volume 17 of Issue 2